Systemic Inflammation: Clinical Trials

8 trials for Systemic Inflammation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown, 2 completed, 1 enrolling by invitation, 1 not yet recruiting. 8 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 28Unknown 3, Completed 2, Enrolling by invitation 1, Not yet recruiting 1, Withdrawn 1
Phase 11Withdrawn 1
Phase 31Unknown 1

Follow Systemic Inflammation: new trials by email Literature Review of Systemic Inflammation trials Research Report on Systemic Inflammation

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
REducing Systemic Inflammation With LOw-dose Colchicine to ImproVE Cardiovascular Calcification in Chronic Kidney Disease: A Pilot Randomized Open-Label Trial
Low-dose Colchicine at 0.5mg daily, Usual Care - Chronic Kidney Disease Mineral and Bone Disorder, Cognitive Function
Phase 2Not yet recruitingUniversity of Texas Southwestern Medical Center602026-10-302026-11-04
Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2
IV normal saline, IV immunoglobulin - Systemic Inflammation, Neuroinflammation
Phase 2Enrolling by invitationNational Institute of Neurological Disorders and Stroke (NINDS)452023-07-102026-11-10
Symbiotics and Systemic Inflammation in Chronic Kidney Disease
probiotic Vivomixx®, prebiotic Orafti®Synergy1, Placebo - Chronic Renal Failure, Diabete Type 2
Phase 2UnknownCentre Hospitalier Universitaire de Besancon622020-11-212022-08-03
Preventing Systemic Inflammation After Cardiac Surgery With Alkaline Phosphatase
RESCAP®, placebo - Systemic Inflammation, Cardiopulmonary-bypass
Phase 2 / Phase 3UnknownAlloksys Life Sciences B.V.12502017-11-012024-04-19
Influence of In-line Microfilters on Systemic Inflammation in Adult Critically Ill Patients
In-line microfilter (Supor IV Filter; Pall Corporation, Port Washington, New York) - Systemic Inflammation
Phase 2CompletedUniversity of Salzburg5042012-04-012015-06-02
Cardiovascular Effects of Aerosols in Residences Study
HEPA Filter, HEPA Filtration Placebo - Endothelial Dysfunction, Systemic Inflammation
Phase 2CompletedSimon Fraser University832011-11-012014-04-14
Statins To Treat Adult Cystic Fibrosis
Simvastatin, placebo - Cystic Fibrosis, Systemic Inflammation
Phase 1 / Phase 2WithdrawnUniversity of British Columbia2010-05-012014-01-30
Use of Flaxseed(Alpha Linolenic Acid) Powder in Morbidly Obese Patients With Systemic Inflammation
Placebo, Alpha-linolenic acid/ALA, Alpha linolenic acid/ALA - Morbid Obesity, Atherosclerosis
Phase 2UnknownUniversity of Sao Paulo902007-08-012012-09-28

Narrower conditions

Inflammation (3)  ·  Atherosclerosis (1)  ·  Bone Diseases (1)  ·  COVID-19 (1)  ·  Calcinosis (1)  ·  Chronic Kidney Disease-Mineral and Bone Disorder (1)  ·  Critical Illness (1)  ·  Cystic Fibrosis (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Kidney Failure, Chronic (1)  ·  Neuroinflammatory Diseases (1)  ·  Obesity (1)  ·  Obesity, Morbid (1)  ·  Pathologic Processes (1)  ·  Peripheral Arterial Disease (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (6)  ·  Pathologic Processes (5)  ·  Disease Attributes (4)  ·  Chronic Disease (3)  ·  Nutritional and Metabolic Diseases (3)  ·  Arterial Occlusive Diseases (2)  ·  Arteriosclerosis (2)  ·  Cardiovascular Diseases (2)  ·  Endocrine System Diseases (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Kidney Diseases (2)  ·  Lung Diseases (2)  ·  Male Urogenital Diseases (2)  ·  Metabolic Diseases (2)

Interventions

Docosahexaenoic Acids (1)  ·  Fatty Acids, Omega-6 (1)  ·  Immunoglobulins, Intravenous (1)  ·  Linseed Oil (1)  ·  Saline Solution (1)  ·  Simvastatin (1)

Sponsors

Alloksys Life Sciences B.V. (1)  ·  Centre Hospitalier Universitaire de Besancon (1)  ·  National Institute of Neurological Disorders and Stroke (NINDS) (1)  ·  Simon Fraser University (1)  ·  University of British Columbia (1)  ·  University of Salzburg (1)  ·  University of Sao Paulo (1)  ·  University of Texas Southwestern Medical Center (1)

Countries

Austria (2)  ·  United States (2)  ·  Australia (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Canada (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Malaysia (1)  ·  Netherlands (1)  ·  Portugal (1)  ·  Russia (1)  ·  Singapore (1)  ·  Spain (1)

Top investigators

Avindra Nath, M.D. (1)  ·  Dominik Wiedemann, Prof.Dr. (1)  ·  Jing Chen, MD (1)  ·  Joel Faintuch, MD,PhD (1)  ·  Martin W Duenser, MD, DESA, EDIC (1)  ·  Patricia C Marques, MD (1)  ·  Paul Man, MD (1)  ·  Ryan Allen, PhD (1)

Results publications

PMID 25896330, PMID 26538309